Antimicrobial Agents — MCQs

Antimicrobial Agents Indian Medical PG Practice Questions and MCQs

Question 231: Which anti-tuberculosis drugs are safe in hepatic failure?

A. Pyrazinamide and ethambutol
B. Isoniazid and Rifampicin
C. Streptomycin and Ethambutol (Correct Answer)
D. Rifampicin and Streptomycin

Explanation: ### Explanation **Core Concept: Drug Metabolism and Hepatotoxicity** The management of tuberculosis in patients with hepatic failure requires selecting drugs that are not metabolized by the liver and lack hepatotoxic potential. Most first-line anti-tubercular drugs (ATD) are hepatotoxic, but **Streptomycin** and **Ethambutol** are the notable exceptions [2]. **Why Option C is Correct:** * **Ethambutol:** It is primarily excreted unchanged in the urine (approx. 80%). It does not undergo significant hepatic metabolism and is not considered hepatotoxic [3]. * **Streptomycin:** As an aminoglycoside, it is highly polar and is excreted entirely unchanged via glomerular filtration in the kidneys. It has no hepatic metabolism, making it safe for the liver (though it requires dose adjustment in renal failure) [2]. **Why Other Options are Incorrect:** * **Isoniazid (H), Rifampicin (R), and Pyrazinamide (Z):** These are the "Big Three" hepatotoxic drugs [1]. * **Pyrazinamide** is the most hepatotoxic of all first-line agents [1]. * **Isoniazid** produces toxic metabolites (acetylhydrazine) via the NAT2 pathway. * **Rifampicin** can cause cholestatic jaundice and induces microsomal enzymes. * Therefore, any option containing H, R, or Z (Options A, B, and D) is incorrect for a patient with hepatic failure. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Hepatotoxicity:** Pyrazinamide > Isoniazid > Rifampicin. * **Safe Regimen in Liver Disease:** In patients with unstable/severe liver disease, the WHO recommends a "Hepatosafe Regimen" typically consisting of **Streptomycin, Ethambutol, and a Fluoroquinolone** (like Levofloxacin). * **Monitoring:** If ALT/AST levels rise >3 times the upper limit of normal with symptoms, or >5 times without symptoms, hepatotoxic drugs must be stopped immediately [1].

Question 232: What is the mechanism of action of amphotericin B?

A. Inhibitor of cell wall synthesis
B. Alters the permeability of the fungal cell membrane (Correct Answer)
C. Inhibitor of protein synthesis
D. Acts as an antibody against fungi

Explanation: Explanation: **Mechanism of Action:** Amphotericin B is a **polyene antifungal** [1], [3]. Its mechanism of action centers on its high affinity for **ergosterol**, a vital component of the fungal cell membrane (analogous to cholesterol in humans) [2]. Amphotericin B molecules bind to ergosterol and aggregate to form **transmembrane pores/channels** [2], [4]. These pores disrupt the membrane's integrity, leading to the leakage of intracellular ions (like Potassium) and small molecules, ultimately resulting in fungal cell death (fungicidal action) [2]. **Analysis of Options:** * **Option A:** Inhibitors of cell wall synthesis include **Echinocandins** (e.g., Caspofungin), which inhibit $\beta$-(1,3)-D-glucan synthase [3]. * **Option C:** Inhibitors of protein synthesis are typically antibacterial agents (e.g., Aminoglycosides, Tetracyclines). Most antifungals do not target ribosomes. * **Option D:** Amphotericin B is a chemical compound derived from *Streptomyces nodosus* [1], not an antibody (immunoglobulin). **NEET-PG High-Yield Pearls:** * **Spectrum:** It is the "Gold Standard" for most systemic fungal infections (Mucormycosis, Cryptococcosis, Aspergillosis). * **Resistance:** Occurs if the fungus decreases the ergosterol content in its membrane. * **Adverse Effects:** * **Infusion-related:** Fever, chills ("Shake and Bake" reaction). * **Dose-limiting toxicity:** **Nephrotoxicity** (causes permanent damage in high cumulative doses; managed by saline loading) [1]. * **Electrolyte imbalance:** Hypokalemia and Hypomagnesemia. * **Liposomal Amphotericin B:** Developed to reduce nephrotoxicity by targeting the drug specifically to fungal cells and sparing mammalian renal cells [2].

Question 233: What is the drug of choice for malaria in pregnancy?

A. Proguanil
B. Chloroquine (Correct Answer)
C. Artemesin
D. Halofantrine

Explanation: **Explanation:** The management of malaria in pregnancy is a high-yield topic for NEET-PG, as it requires balancing maternal efficacy with fetal safety. **1. Why Chloroquine is the Correct Answer:** Chloroquine remains the **drug of choice (DOC)** for the treatment of uncomplicated malaria caused by *Plasmodium vivax* or chloroquine-sensitive *P. falciparum* in all trimesters of pregnancy. It is considered safe, non-teratogenic, and has a well-established safety profile for the developing fetus. In areas where *P. vivax* is prevalent, it effectively targets the erythrocytic stages. **2. Analysis of Incorrect Options:** * **Proguanil (A):** While safe in pregnancy, it is rarely used as monotherapy for treatment due to slow action and high resistance. It is typically used for prophylaxis in combination with Atovaquone (Malarone), which is generally avoided in pregnancy unless benefits outweigh risks. * **Artemisinin (C):** While ACT (Artemisinin-based Combination Therapy) is the DOC for chloroquine-resistant malaria in the 2nd and 3rd trimesters, Chloroquine is still the primary answer for "malaria in pregnancy" unless resistance is specified. Note: Quinine + Clindamycin is preferred for resistant cases in the 1st trimester. * **Halofantrine (D):** This drug is **contraindicated** in pregnancy due to potential embryotoxicity and its known risk of QT interval prolongation (cardiotoxicity). **3. Clinical Pearls for NEET-PG:** * **Vivax Malaria:** Chloroquine is the DOC. However, **Primaquine is strictly contraindicated** in pregnancy due to the risk of fetal hemolysis (G6PD status of the fetus is unknown). * **Falciparum (Resistant) Malaria:** * *1st Trimester:* Quinine + Clindamycin (7 days). * *2nd & 3rd Trimester:* ACT (Artemether-Lumefantrine is most common). * **Severe Malaria:** IV Artesunate is the DOC for all trimesters, as the risk of maternal death outweighs potential fetal risks.

Question 234: Acyclovir triphosphate inhibits the synthesis of DNA by competing with which of the following?

A. 4-Oxyadenosine monophosphate
B. 2-Oxyadenosine diphosphate
C. 2'-deoxyguanosine triphosphate (Correct Answer)
D. 4'-deoxyguanosine triphosphate

Explanation: ### Explanation **Mechanism of Action:** Acyclovir is a guanosine analog. To become active, it must undergo three stages of phosphorylation. The first step is catalyzed by viral **thymidine kinase**, converting it to acyclovir monophosphate. Host cell kinases then convert it into the active form, **acyclovir triphosphate**. Acyclovir triphosphate inhibits viral DNA synthesis via two mechanisms: 1. **Competitive Inhibition:** It acts as a structural analog of **deoxyguanosine triphosphate (dGTP)**. It competes with dGTP for the viral DNA polymerase enzyme. 2. **Chain Termination:** Once incorporated into the growing DNA strand, it acts as a "terminator" because it lacks the **3'-hydroxyl group** necessary for the attachment of the next nucleotide. **Analysis of Options:** * **Option C (Correct):** Acyclovir is a synthetic analog of guanine; therefore, its triphosphate form competes specifically with the natural substrate **2'-deoxyguanosine triphosphate (dGTP)**. * **Option A & B:** Adenosine analogs (like Vidarabine) would compete with adenosine nucleotides, not guanosine analogs like Acyclovir. * **Option D:** 4'-deoxyguanosine triphosphate is not the standard physiological substrate for DNA polymerase; the natural building block is the 2'-deoxy form. **High-Yield Clinical Pearls for NEET-PG:** * **Selectivity:** Acyclovir is highly selective because the initial phosphorylation requires **viral thymidine kinase**, which is absent in non-infected host cells. * **Resistance:** Most commonly occurs due to the loss of viral thymidine kinase activity (seen in immunocompromised patients). * **Drug of Choice:** For Herpes Simplex Virus (HSV) encephalitis, genital herpes, and Varicella-Zoster Virus (VZV) infections. * **Adverse Effect:** Obstructive crystalline nephropathy (prevented by adequate hydration).

Question 235: Which of the following statements about fluoroquinolones is true?

A. Ciprofloxacin is the drug of choice for Anthrax.
B. Ciprofloxacin and levofloxacin are the only fluoroquinolones effective against Pseudomonas.
C. First-generation fluoroquinolones have a narrow spectrum of action.
D. All of the above. (Correct Answer)

Explanation: Fluoroquinolones (FQs) are a vital class of bactericidal antibiotics that inhibit DNA synthesis by targeting **DNA gyrase** (Gram-negative) and **Topoisomerase IV** (Gram-positive). **Explanation of Options:** * **Option A:** Ciprofloxacin is indeed the **Drug of Choice (DOC)** for both the prophylaxis and treatment of *Bacillus anthracis* (Anthrax). While doxycycline is an alternative, FQs are preferred due to their high efficacy. * **Option B:** Among the commonly used FQs, Ciprofloxacin and Levofloxacin are the primary agents with significant **anti-pseudomonal** activity. Ciprofloxacin is the most potent against *Pseudomonas aeruginosa*, while newer "respiratory quinolones" like Moxifloxacin lack reliable activity against this pathogen. * **Option C:** The classification of FQs is based on their spectrum. **First-generation** agents (e.g., Norfloxacin) have a narrow spectrum, primarily targeting Gram-negative aerobes, and are largely restricted to treating urinary tract infections (UTIs). **Why "All of the Above" is correct:** Each statement accurately describes a fundamental pharmacological property or clinical application of the fluoroquinolone class. **High-Yield NEET-PG Pearls:** * **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin are called "respiratory quinolones" due to enhanced activity against *S. pneumoniae*. * **Moxifloxacin:** It is the only FQ primarily excreted via the **biliary route**; therefore, it does not require dose adjustment in renal failure but cannot be used for UTIs. * **Adverse Effects:** Watch for **tendon rupture** (Achilles tendon), QT prolongation, and dysglycemia. They are generally contraindicated in pregnancy and children due to **cartilage toxicity**.

Question 236: Which of the following drug classes is known to cause ototoxicity and nephrotoxicity?

A. Antiemetics
B. Antivirals
C. Antifungals
D. Antibiotics (Correct Answer)

Explanation: ### Explanation **Correct Option: D (Antibiotics)** The combination of **ototoxicity** (damage to the inner ear) and **nephrotoxicity** (damage to the kidneys) is a classic adverse effect profile associated with specific classes of antibiotics, most notably **Aminoglycosides** (e.g., Gentamicin, Amikacin, Streptomycin) and **Glycopeptides** (e.g., Vancomycin). * **Mechanism:** Aminoglycosides accumulate in the renal tubular cells (causing acute tubular necrosis) and the endolymph/perilymph of the inner ear (destroying hair cells). This damage is often dose-dependent and can be potentiated when these drugs are used concurrently. **Analysis of Incorrect Options:** * **A. Antiemetics:** While some (like Metoclopramide) can cause extrapyramidal symptoms, they are not typically associated with this specific dual toxicity. * **B. Antivirals:** While some antivirals like Acyclovir or Cidofovir are nephrotoxic, they do not characteristically cause ototoxicity. * **C. Antifungals:** Amphotericin B is notoriously nephrotoxic ("Ampho-terrible"), but ototoxicity is not a standard feature of antifungal therapy. **High-Yield Clinical Pearls for NEET-PG:** 1. **Aminoglycosides:** Ototoxicity can be **vestibular** (Streptomycin, Gentamicin) or **cochlear** (Amikacin, Neomycin). Neomycin is the most nephrotoxic and is thus restricted to topical or oral use. 2. **Drug Interactions:** The risk of ototoxicity increases significantly when Aminoglycosides are combined with **Loop Diuretics** (e.g., Furosemide, Ethacrynic acid). 3. **Red Man Syndrome:** Associated with Vancomycin (due to histamine release), which also shares the nephro/oto-toxicity profile. 4. **Monitoring:** Therapeutic Drug Monitoring (TDM) is essential for Aminoglycosides to prevent these toxicities.

Question 237: Which anti-tubercular drug is contraindicated in pregnancy?

A. Streptomycin (Correct Answer)
B. Isoniazid
C. Rifampicin
D. Pyrazinamide

Explanation: **Explanation:** The correct answer is **Streptomycin**. **Why Streptomycin is contraindicated:** Streptomycin is an aminoglycoside that is strictly contraindicated in pregnancy (FDA Category D). It crosses the placental barrier and is known to be **ototoxic** to the developing fetus. Exposure during pregnancy can lead to permanent **congenital deafness** (damage to the 8th cranial nerve) and potential nephrotoxicity in the neonate. **Analysis of Incorrect Options:** * **Isoniazid (INH):** Considered safe in pregnancy. However, it is usually co-administered with **Pyridoxine (Vitamin B6)** to prevent peripheral neuropathy in both the mother and the fetus. * **Rifampicin:** Considered safe and is a core component of the RNTCP/WHO regimen for pregnant women with TB. It does not have documented teratogenic effects in humans. * **Pyrazinamide:** While older guidelines were cautious due to limited data, the WHO and current Indian national guidelines (NTEP) consider Pyrazinamide safe for use in pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Regimen:** The standard 6-month 2HREZ/4HR regimen is recommended for pregnant women. * **Ethambutol:** Also considered safe; it does not cause fetal ocular toxicity. * **Second-line drugs:** Most second-line drugs (like Kanamycin, Ethionamide, and Fluoroquinolones) are generally avoided in pregnancy due to risks of teratogenicity or cartilage damage. * **Breastfeeding:** All first-line anti-tubercular drugs are compatible with breastfeeding as they are excreted in breast milk in negligible amounts.

Question 238: Which of the following is NOT indicated for the treatment of anaerobic colitis?

A. Metronidazole
B. Aminoglycoside (Correct Answer)
C. Amikacin
D. Piperacillin-tazobactam

Explanation: The correct answer is **Aminoglycoside** (and by extension, **Amikacin**, which is a specific aminoglycoside). ### **Explanation** The fundamental pharmacological principle here is that **Aminoglycosides are strictly ineffective against anaerobic bacteria.** Their mechanism of action involves active transport across the bacterial cell membrane, a process that is **oxygen-dependent**. In the anaerobic environment of the colon (or in anaerobic infections), this transport mechanism fails, rendering the drug unable to reach its target (the 30S ribosome). Therefore, aminoglycosides lack activity against anaerobes like *Bacteroides fragilis* or *Clostridium* species. ### **Analysis of Options** * **A. Metronidazole:** This is the "gold standard" for anaerobic infections. It is a prodrug that is activated only in anaerobic cells to form reactive intermediates that damage bacterial DNA. * **B & C. Aminoglycoside/Amikacin:** As explained, these require oxygen for uptake. They are primarily used for aerobic Gram-negative bacilli (e.g., *Pseudomonas*, *E. coli*). * **D. Piperacillin-tazobactam:** This is a broad-spectrum β-lactam/β-lactamase inhibitor combination. The addition of tazobactam provides excellent coverage against β-lactamase-producing anaerobes. ### **NEET-PG High-Yield Pearls** * **Anaerobic Coverage "Rule of Thumb":** Use **Metronidazole** for infections "below the diaphragm" and **Clindamycin** for infections "above the diaphragm" (though both have cross-over). * **Aminoglycoside Resistance:** The most common mechanism of resistance is the production of **aminoglycoside-modifying enzymes** (transferases). * **Synergy:** Aminoglycosides are often combined with Cell Wall Inhibitors (Penicillins/Vancomycin) to treat Enterococcal endocarditis because the cell wall damage facilitates aminoglycoside entry.

Question 239: Oral vancomycin may be given in which of the following conditions?

A. Plague
B. Prostatitis
C. Tularemia
D. Pseudomembranous colitis (Correct Answer)

Explanation: **Explanation:** **Vancomycin** is a glycopeptide antibiotic that is poorly absorbed from the gastrointestinal tract (GIT) when administered orally. While this poor bioavailability makes it unsuitable for systemic infections, it is highly advantageous for treating local infections within the gut. **Why Option D is Correct:** **Pseudomembranous colitis** is caused by an overgrowth of *Clostridioides difficile* (C. diff), usually following broad-spectrum antibiotic use. Because oral vancomycin remains concentrated in the intestinal lumen and is not absorbed into the bloodstream, it acts directly on the bacteria in the colon. It is currently a first-line treatment for C. diff infections. **Why Other Options are Incorrect:** * **A & C (Plague and Tularemia):** Both are caused by Gram-negative bacteria (*Yersinia pestis* and *Francisella tularensis*, respectively). Vancomycin is only active against Gram-positive organisms. Furthermore, these are systemic infections requiring drugs with high systemic bioavailability (e.g., Streptomycin, Gentamicin, or Doxycycline). * **B (Prostatitis):** This is a systemic/tissue-level infection. Oral vancomycin would never reach the prostate due to lack of absorption from the gut. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Inhibits bacterial cell wall synthesis by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan pentapeptide. * **Route of Administration:** Given **IV** for systemic infections (e.g., MRSA) and **Orally** *only* for *C. difficile* colitis. * **Adverse Effects:** "Red Man Syndrome" (infusion-related histamine release; prevented by slow infusion), nephrotoxicity, and ototoxicity. * **Drug of Choice:** Vancomycin is the gold standard for **MRSA** (Methicillin-resistant *Staphylococcus aureus*).

Question 240: Which drug is known to cause pseudomembranous colitis?

A. Clindamycin (Correct Answer)
B. Clindamycin
C. Vancomycin
D. Penicillin

Explanation: **Explanation:** **Pseudomembranous colitis** is a severe inflammation of the colon caused by an overgrowth of the toxin-producing bacterium ***Clostridioides difficile*** (formerly *Clostridium difficile*). This occurs when broad-spectrum antibiotics disrupt the normal protective gut flora. **1. Why Clindamycin is the correct answer:** While many antibiotics can trigger this condition, **Clindamycin** is classically associated with the highest risk relative to its use. It is a lincosamide that effectively suppresses normal colonic anaerobes, creating an ecological niche for *C. difficile* to proliferate and release toxins (Toxin A and B), leading to mucosal damage and the formation of characteristic "pseudomembranes." **2. Analysis of Incorrect Options:** * **Vancomycin:** This is actually a **treatment** for pseudomembranous colitis (administered orally). It is not a common cause; rather, it is the drug of choice for severe or recurrent *C. difficile* infections. * **Penicillin:** While narrow-spectrum penicillins rarely cause this condition, broad-spectrum derivatives (like Ampicillin or Amoxicillin) are frequent causes. However, in a "single best answer" scenario, Clindamycin remains the classic textbook association. **3. NEET-PG High-Yield Pearls:** * **Most common cause overall:** Currently, **Fluoroquinolones**, Cephalosporins, and Ampicillin are more frequent causes in clinical practice due to their higher volume of use. * **Drug of Choice (DOC):** For the first episode, **Fidaxomicin** or **Oral Vancomycin** are preferred. **Metronidazole** is now reserved for mild cases in resource-limited settings. * **Diagnosis:** Confirmed by detecting *C. difficile* toxins in stool or via sigmoidoscopy showing yellow-white plaques (pseudomembranes). * **Key Association:** If a patient develops profuse watery diarrhea after treatment for a dental infection or anaerobic lung abscess (where Clindamycin is often used), suspect pseudomembranous colitis.

Practice by Chapter

Beta-Lactam Antibiotics

Practice Questions

Aminoglycosides

Practice Questions

Macrolides and Ketolides

Practice Questions

Tetracyclines

Practice Questions

Quinolones

Practice Questions

Sulfonamides and Trimethoprim

Practice Questions

Antimycobacterial Drugs

Practice Questions

Antifungal Agents

Practice Questions

Antiviral Drugs

Practice Questions

Antiparasitic Agents

Practice Questions

Principles of Antimicrobial Selection

Practice Questions

Antimicrobial Resistance

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free